Paper6445274
Pharmacokinetics of zimelidine. Systemic availability of zimelidine and norzimelidine in human volunteers.
Brown D and 5 others. Eur J Clin Pharmacol, 1980. Cited by 37 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pharmacokinetics of zimelidine. Systemic availability of zimelidine and norzimelidine in human volunteers. Papers, record 6445274. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6445274
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacokinetics of zimelidine. Systemic availability of zimelidine and norzimelidine in human volunteers.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antidepressive Agents | Major topic |
| Brompheniramine | Major topic |
| Pyridines | Major topic |
| Administration, Oral | |
| Adult | |
| Biological Availability | |
| Dealkylation | |
| Electrocardiography | |
| Humans | |
| Injections, Intravenous | |
| Male | |
| Time Factors | |
| Zimeldine |
Source PubMed
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 834,363 | Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analogues. | Neuropharmacology | 1977 | https://conductscience.org/library/papers/834363 | PubMed |
| 2 | 113,803 | Zimelidine: a therapeutic and pharmacokinetic study in depression. | Psychopharmacology (Berl) | 1979 | https://conductscience.org/library/papers/113803 | PubMed |
| 3 | 1,173,529 | Tricyclic antidepressant agents. II. Effect of oral administration on the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices of the midbrain-hypothalamus region of the rat. | Acta Pharmacol Toxicol (Copenh) | 1975 | https://conductscience.org/library/papers/1173529 | PubMed |
| 4 | 1,173,528 | Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain. | Acta Pharmacol Toxicol (Copenh) | 1975 | https://conductscience.org/library/papers/1173528 | PubMed |
| 5 | 947,293 | (Z)-dimethylamino-1-(4-bromophenyl)-1-(3-pyridyl) propene (h 102/09), a new selective inhibitor of the neuronal 5-hydroxytryptamine uptake. | Acta Pharmacol Toxicol (Copenh) | 1976 | https://conductscience.org/library/papers/947293 | PubMed |
| 6 | 5,567,579 | Influence of first-pass effect on availability of drugs on oral administration. | J Pharm Sci | 1971 | https://conductscience.org/library/papers/5567579 | PubMed |
| 7 | 6,450,684 | Biochemical effects of zimelidine in man. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6450684 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,768,073 | Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo. | Psychopharmacology (Berl) | 1980 | https://conductscience.org/library/papers/6768073 | PubMed |
| 6,455,297 | Pharmacokinetics of zimelidine in humans--plasma levels and urinary excretion of zimelidine and norzimelidine after intravenous and oral administration of zimelidine. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6455297 | PubMed |
| 6,228,368 | Pharmacokinetic study of zimelidine using a new GLC method. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6228368 | PubMed |
| 6,226,335 | Possible hepatotoxicity of zimelidine. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6226335 | PubMed |
| 6,215,240 | Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness. | Drugs | 1982 | https://conductscience.org/library/papers/6215240 | PubMed |
| 6,164,072 | Effects of zimelidine on serotoninergic and noradrenergic neurons after repeated administration in the rat. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6164072 | PubMed |
| 3,161,742 | Influence of renal failure on the kinetics of zimeldine and norzimelidine. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3161742 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6445274
GET https://conductscience.org/api/papers/v1/6445274/authors